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Abstract
Objective: The main objective of this study was to assess the influence of gas mixtures on in vitro
Plasmodium falciparum growth and 50% inhibitory concentration (IC50) for chloroquine.
Methods: The study was performed between February 2004 and December 2005. 136 Plasmodium
falciparum isolates were used to evaluate gas mixtures effect on IC50 for chloroquine by isotopic
microtest. The oxygen effect on asexual blood cycle of 3D7 and W2 clones was determined by thin
blood smears examination and tritiated hypoxanthine uptake.
Results:  From 5% O2 to 21% O2 conditions, no parasiticide effect of O2 concentration was
observed in vitro on the clones 3D7 and W2. A parasitostatic effect was observed during the
exposure of mature trophozoïtes and schizonts at 21% O2 with an increase in the length of
schizogony. The chloroquine IC50 at 10% O2 were significantly higher than those at 21% O2, means
of 173.5 nM and 121.5 nM respectively (p < 0.0001). In particular of interest, among the 63 isolates
that were in vitro resistant to chloroquine (IC50 > 100 nM) at 10% O2, 17 were sensitive to
chloroquine (IC50 < 100 nM) at 21% O2.
Conclusion: Based on these results, laboratories should use the same gas mixture to realize
isotopic microtest. Further studies on comparison of isotopic and non-isotopic assays are needed
to establish a standardized in vitro assay protocol to survey malaria drug resistance.
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Background
Drug resistance of Plasmodium falciparum, the most deadly
human malaria parasite with nearly 500 millions of new
clinical cases each year [1], makes malaria control more
difficult [2,3]. There are basically three approaches to the
assessment of the antimalarial drug susceptibility of P. fal-
ciparum: in vivo assays as defined by the World Health
Organization [4], in vitro assays and molecular markers of
resistance [5].
In a number of laboratories surveying malaria drug resist-
ance, in vitro tests are performed using the uptake of a radi-
olabelled nucleic acid precursor [3H]-hypoxanthine [6] as
a marker of parasite growth. Others methods can be used:
the WHO schizont maturation tests by optical microscopy
(Mark III) with pre-dosed plates [7], which was based on
the method of Rieckmann et al [8] and of Wernsdorfer [9],
a flow cytometric analysis of propidium iodide incorpora-
tion into parasite, which permits a stage-specific evalua-
tion of antimalarial compounds [10], and colorimetric
assays with the measurement of Histidine Rich Protein II
(HRP2) by an enzyme-linked immunosorbent assay
(ELISA) [11,12] and the DELI-microtest (Double-site
Enzyme-linked Lactate dehydrogenase Immunosorbent
assay) [13,14].
Many factors can influence the results of the chemosus-
ceptibility tests [15]: the initial parasitaemia, the haemat-
ocrit, the time of incubation, the time point when [3H]-
hypoxanthine is added, the use of serum substitutes and
the gas mixture. Laboratories using isotopic microtest to
monitor drug resistance work at different oxygen tensions:
3% O2 [10], 5% O2 [11,12], 10% O2 [16], in candle jars
[13,14] (which corresponds to approximately 15% O2
[17]) and 21% O2 [15] (in CO2 incubators). WHO recom-
mends the use of a candle jar in their in vitro microtests
(Mark III). But all have adopted the same threshold for the
resistance to antimalarial compounds under different oxy-
gen tensions. The aim of this study was to evaluate the
influence of oxygen on the asexual blood cycle and the in
vitro chemosusceptibility of P. falciparum to chloroquine
in order to contribute to the establishment of a standard-
ized in vitro assay protocol.
Methods
Isolates of P. falciparum
Between February 2004 and December 2005, 136 P. falci-
parum isolates were obtained from patients attending the
North Hospital in Marseille [18] (France). Venous blood
was collected into Vacutainer ACD tubes (Becton Dickin-
son, Rutherford, NJ) before treatment and transported at
4°C to the laboratory in Marseilles, that is associated to
the French National Malaria Reference Center. Thin blood
smears were stained using a RAL kit (Réactifs RAL, Paris,
France) and examined to determine parasite density. Sam-
ples with parasitaemia ranging from 0.01% to 6.2% were
used to test drug sensitivity. Parasitized erythrocytes were
washed three times in RPMI 1640 medium (Invitrogen,
Paisley, United Kingdom). If parasitaemia exceeded 0.8%,
infected erythrocytes were diluted to 0.5–0.8% with unin-
fected erythrocytes and resuspended in culture medium to
a haematocrit of 1.5%. Susceptibility to chloroquine was
determined after suspension in RPMI 1640 medium. The
suspensions were supplemented with 10% human serum
(AbCys, Paris, France) and buffered with 25 mM HEPES
(Sigma, St. Louis, MO) and 25 mM NaHCO3 (Sigma). Iso-
lates were used for 60-hr experiments at two different gas
mixtures under 10% O2, 5% CO2, 85% N2 in a CO2 water
jacketed incubator series II (Model 3141, Forma Scientific,
Inc.) or 21% O2, 5% CO2, 74% N2 in a CO2 incubator
(Model MCO-17 AIC, Sanyo).
Parasite clones
Chloroquine sensitive 3D7 clone and chloroquine resist-
ant W2 clone (MR4 Resource Center) were used in this
study. They were maintained in continuous culture as pre-
viously described [19] at 6% haematocrit using type O+
(3D7) or type A+ (W2) human erythrocytes in the same
conditions as described above at 37°C under a 5% CO2,
5% O2, 90% N2 gas mixture and a humidity of 95%. Cul-
ture medium was changed every day, viability and parasi-
taemia of cultured parasites were calculated by light
microscopy analysis of blood smear stained with RAL®
555 (Réactifs RAL, France), (5,000 erythrocytes counted
per blood smear). Blood smear pictures were performed
using a digital camera (Digital Camera DXM 1200,
Nikon), and analyzed with the software Lucia 4.8
(Nikon). Parasite synchronization was performed by
sorbitol treatment (D-Sorbitol, ICN Biomedicals) as pre-
viously described [20]. To obtain tightly synchronized
cultures, two sorbitol treatments were carried out 12 h
apart. Approximately 48 h after the initial synchroniza-
tion, the cultures were synchronized again to eliminate
any residual schizonts. Clonality was verified every month
using PCR genotyping of polymorphic genetic markers
(msp1, msp2 and microsatellite loci [21,22]).
Drug
Chloroquine diphosphate was obtained from Sigma
Chemical Co. (St. Louis, Mo, U.S.A.). Two-fold serial dilu-
tions of chloroquine were prepared in sterile, distilled
water. Final concentrations ranging from 5 nM to 3200
nM were distributed in triplicate into Falcon 96-well flat-
bottom plates (Becton Dickinson, Franklin Lakes, N.J.),
which were dried.
Oxygen effects on asexual blood cycle of P. falciparum
Synchronous cultures of 3D7 or W2 were divided in three
subcultures at 2% initial parasitaemia for 3D7 and 0.5%
for W2 and 3% haematocrit under three different oxygenMalaria Journal 2007, 6:44 http://www.malariajournal.com/content/6/1/44
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tensions 5% O2, 10% O2 and 21% O2 in three different
experiments with duplicates. Culture mediums were not
replaced during the experiments. Blood smears were car-
ried out at different times to evaluate parasitaemia and
percentages of different stages of parasite (5,000 erythro-
cytes were counted per blood smear in blind by two differ-
ent examiners). The same experiments (three different
experiments with duplicates) were undertaken with 3D7
parasites with only ten hours exposures of rings stages,
trophozoïtes stages or schizonts stages under 21% O2, 5%
CO2, 74% N2 gas mixture and under 5% O2, 5% CO2,
90% N2 gas mixture in a CO2 water jacketed incubator
series II (Model 3131, Forma Scientific, Inc.) during the
rest of the cycle to assess a stage susceptibility of oxygen
effect.
Tritiated hypoxanthine uptake
200 μl of the suspension of no parasitized and parasitized
erythrocytes (1% parasitaemia, 2% haematocrit) was dis-
tributed in 96-well plates (three different experiments
with six measurements). Parasite growth was assessed by
adding 1 μCi of [3H]-hypoxanthine with a specific activity
of 14.1 Ci/mmol (Perkin Elmer, Meriden, NJ) to each
well. Plates were incubated for different periods and at dif-
ferent parasites stages at 37°C under 21% O2, 5% CO2,
74% N2 or 10% O2, 5% CO2, 85% N2 gas mixture and a
humidity of 95%. Duplicate wells were used to make thin
blood smears to evaluate parasitaemia and parasite stages.
Immediately after incubation the plates were frozen and
then thawed to lyse erythrocytes. The content of each well
was collected on standard filter microplates (Unifilter™
GF/B, Perkin Elmer) and washed using a cell harvester
(Filtermate™ Cell Harvester, Packard, Meriden, NJ). Filter
microplates were dried and 25 μl of scintillation cocktail
(Microscint™ O, Perkin Elmer) was placed in each well.
Radioactivity incorporated (in counts per minute, cpm)
by the parasites was measured using a scintillation coun-
ter (Top Count™, Perkin Elmer).
Drug susceptibility assays
The isotopic micro drug susceptibility test used in this
study was performed as described previously [23]. The
50% inhibitory concentration (IC50), i.e. the drug concen-
tration corresponding to 50% of the uptake of [3H]-
hypoxanthine by the parasites in drug-free control wells,
was determined by nonlinear regression analysis of log
dose-response curves. Data were analyzed after logarith-
mic transformation and expressed as the geometric mean
IC50 with 95% confidence intervals. The cut-off value for
in vitro resistance to chloroquine is 100 nM [24].
Statistical analysis
The different results were analyzed with the software
STATA 9.0 using a Chi-square test for related samples, a
Student's T test or a Wilcoxon signed-rank test (as needed)
for related samples. Differences were considered statisti-
cally significant when p < 0.05.
Results
In order to determine the effect of oxygen on asexual
blood stages of P. falciparum, synchronous cultures of 3D7
were exposed to 5, 10 and 21% O2 during two cycles of
parasites. As shown in Figure 1A, there were no significant
difference between parasitaemia or parasite stage distribu-
tion under 5 and 10% O2 during all the experiment. On
the contrary, from 35 h to the rest of experimental points,
a significant difference between parasite stages was
observed (Figure 2), for example at 40 h, there were 42%
of rings and 44.9% of schizonts under 5% O2 and 21.7%
of rings and 67.6% of schizonts under 21% O2 (p < 0.001,
Chi-square test). After the complete reinvasion around 60
h, parasitaemia were the same in the three experimental
conditions and no morphologic alteration were observed
by light microscopy (Figures 3A and 3B). These results
have shown that parasite exposure under 21% O2 had no
lethal effect on parasites, but increased the length of
schizogony. Moreover, only mature trophozoïtes and sch-
izonts were susceptible to an effect of exposure to 21% O2
(Figure 4).
The delay was also observed with W2 clone (Figure 1B),
with a briefer schizogony (8 hours for W2 and 11 hours
3D7) and a higher multiplication index for W2 (% of
infected red blood cells by rings after reinvasion/% of
infected red blood cells by rings at the beginning of the
previous cycle), (8 for W2 and 3 for 3D7).
No significant difference were observed in tritiated hypox-
anthine uptake between 10 and 21% O2 with the two
clones 3D7 and W2 (Figures 5A and 5B), (p = 0.087 and
p = 0.76 respectively). The maximum of incorporation
(around 2,500 cpm with 3D7 and 4,500 cpm with W2)
was achieved at 50 hours with a steady-state until 60
hours for 3D7 and W2 in the two experimental condi-
tions. 3D7 and W2 chloroquine IC50  were evaluated
under 5, 10 and 21% O2 (three experiments). No signifi-
cant difference were observed with 3D7, the IC50 were
15.8 nM [10.8–20.7], 14.1 nM [12.4–16.9], 17.6 nM
[14.1–21.1] under 5% O2, 10% O2 and 21% O2 respec-
tively. On the contrary, with W2 clone, IC50 under 21% O2
was significantly lower than IC50 under 5% O2 and 10%
O2, 83.3 nM [15–168], 299 [228–369] and 277 [192–
322] respectively (p < 0.05, Student's T test).
One hundred and thirty six Plasmodium falciparum isolates
were used to evaluate chloroquine susceptibility at 10%
O2 and 21% O2. Three tests at 10% O2 and 13 tests at 21%
O2 were not interpretable, because of lack of significant
difference in cpm between control-wells and higher chlo-
roquine concentration wells. Chloroquine susceptibilityMalaria Journal 2007, 6:44 http://www.malariajournal.com/content/6/1/44
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of 120 isolates was finally tested at 10 and 21% O2 (Figure
6A). The differences between the chloroquine IC50 of the
120 isolates at 10% O2 and at 21% O2 were statistically
significant (p < 0.0001, Wilcoxon signed-rank test),
means of 173.5 nM with a standard deviation of 168.4
and 121.5 nM with a standard deviation of 106.7 respec-
tively. The median and interquartile (Q25% & Q75%)
values of the chloroquine IC50 at 10% O2 and IC50 at 21%
O2 of the 120 isolates were respectively 127 nM, 30 nM,
258 nM at 10% O2 and 85.9 nM, 36 nM, 168 nM at 21%
Evolution of asexual parasitaemia of synchronous cultures of Plasmodium falciparum under different oxygen tensions Figure 1
Evolution of asexual parasitaemia of synchronous cultures of Plasmodium falciparum under different oxygen 
tensions. Each point represents the mean ± standard deviation of three experiments. A: 3D7 clone. B: W2 clone.
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O2. In particular of interest, 52.5% of isolates had chloro-
quine IC50 > 100 nM at 10% O2 although 42.5% of the
same isolates had chloroquine IC50 > 100 nM at 21% O2.
Moreover, among the 63 isolates which had chloroquine
IC50 > 100 nM at 10% O2, 17 had chloroquine IC50 < 100
nM at 21% O2 (Figure 6B) (i.e. 1/3) although five isolates
only had chloroquine IC50 > 100 nM at 21% O2 among
the 57 isolates which had chloroquine IC50 < 100 nM at
10% O2 (Table 1), (Chi-square test for paired samples, p
< 0.025).
There were no significant difference between the observed
control cpm at 10 (mean 12,607, standard deviation
13,425) and 21% O2 (mean 13,302, standard deviation
14,662).
Discussion
The first works about oxygen effects on P. falciparum asyn-
chronous cultures [17] had shown that microaerophilic
environment allowed an optimal development of para-
sites. Their growth was impossible in strict anaerobic con-
ditions.  P. falciparum possesses a functional
mitochondrial respiratory chain with oxygen consump-
tion [25]. It has been shown that there is some protector
effect of CO2 at high oxygen concentration [17] through
the medium pH which stability (between 7.2 et 7.45) is
required for parasite growth [26]. The analysis of the dif-
ferent parasites stages distribution according to the time
and the oxygen concentration has allowed us to reveal a
possible slow down of cellular cycle without morphologic
alteration of parasites under 21% O2.
Percentages evolution of asexual stages of synchronous culture of 3D7 Plasmodium falciparum clone under different oxygen ten- sions during 86 hours Figure 2
Percentages evolution of asexual stages of synchronous culture of 3D7 Plasmodium falciparum clone under dif-
ferent oxygen tensions during 86 hours. Each percentage represents the mean ± standard deviation of three experiments. 
R: Ring. MT: Mature Trophozoïte: S: Schizont. RO: Rosace. Blue histograms correspond to 5% O2; Purple histograms corre-
spond to 10% O2. Yellow histograms correspond to 21% O2.
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In the present study, the exposure to 21% O2 did not
change parasitaemia growth rate after complete reinva-
sion. Previous studies [27] had shown the same absence
of oxygen effect on synchronous cultures parasitaemia
during four days. Here, it has been shown that the expo-
sure of 3D7 and W2 P. falciparum clones to 21% O2 had
parasitostatic effect by lengthening the schizogony.
Mature stages had a particular susceptibility to high oxy-
gen concentration. Moreover, these results justified to test
drug susceptibility after a 60 hours period of incubation
with [3H]-hypoxanthine. At the end of trophozoïtes stage,
DNA replication begins and is followed by a succession of
S phases during the schizogony [28]. Under 21% O2, the
nucleic acids synthesis decreased from 30 hours for the
two P. falciparum clones comparing to 5% O2 exposure.
Under 5% O2, a low [3H]-hypoxanthine incorporation
took place for the first twenty hours, probably corre-
sponding to RNA synthesis in rings, followed by an
increase between 20 and 30 hours in possible relation
with the beginning of DNA replication at late tropho-
Cell cycle evolution of asexual blood stages of Plasmodium falciparum Figure 3
Cell cycle evolution of asexual blood stages of Plasmodium falciparum. A: 3D7 clone. B: W2 clone. 1: 5% O2. 2: 21% 
O2.
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Table 1: Repartition of drug susceptibility of Plasmodium falciparum isolates at 10% O2 and 21% O2.
21% O2
CQa IC50
b < 100 nM CQ IC50 > 100 nM
10% O2 CQ IC50 < 100 nM 52 5
CQ IC50 > 100 nM 17 46
a CQ: chloroquine.
b IC50: inhibitory concentration 50% (nM).Malaria Journal 2007, 6:44 http://www.malariajournal.com/content/6/1/44
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zoïtes stage [29]. Between 30 and 40 hours, during
schizogony, DNA synthesis increased and the peak was
achieved at 50 hours [30].
In the present study, the chloroquine IC50 at 10% O2 were
significantly higher than those at 21% O2. A previous
study did not show oxygen dependent effects of chloro-
quine on P. falciparum in culture [31], but in that experi-
ment only four strains were tested. In the present work,
among the 63 isolates which had chloroquine IC50 > 100
nM at 10% O2, 17 had chloroquine IC50 < 100 nM at 21%
O2. The effect of gas mixture on the results of chloroquine
chemosusceptibility should led different laboratories
involved in malaria resistance survey to adapt a resistance
threshold for each gas mixture or to use the same condi-
tions to perform isotopic microtests.
Conclusion
Several factors influencing the results of the chemosuscep-
tibility tests (the initial parasitaemia, the haematocrit, the
time of incubation, the time point when [3H]-hypoxan-
thine is added, the use of serum substitutes) have already
been investigated by Basco [15,32]. The present data sug-
gest the importance of the gas mixture on isotopic micro-
test results for chloroquine. Further studies are needed to
evaluate gas mixture impact on isolates susceptibility to
other antimalarial compounds and their correlation with
molecular markers of resistance and in vivo evaluation of
drug efficacy. Other investigations about the preparation
of drug solutions, the storage of pre-dosed culture plates
are required before in vitro drug sensitivity assay can
become a standardized tool for laboratories to validate
the threshold for resistance in respect to the clinical
responses and molecular markers.
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Evolution of asexual parasitaemia of synchronous cultures of Plasmodium falciparum exposed to 21% O2 during ten hours at  ring, trophozoïte or schizont stage Figure 4
Evolution of asexual parasitaemia of synchronous cultures of Plasmodium falciparum exposed to 21% O2 during 
ten hours at ring, trophozoïte or schizont stage. Each point represents the mean ± standard deviation of three experi-
ments.
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at 21% O2; blue plots corresponds to isolates with a switch from resistant at 10% O2 to susceptible at 21% O2.
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